HRPT2 gene alterations in ossifying fibroma of the jaws

Oral Oncology

Volumn 42, Issue 7, 2006, Pages 735-739

  Pimenta, Flávio Juliano ^a   Gontijo Silveira, Letícia Ferreira ^a   Tavares, Gabriela Cordeiro ^a   Silva, Andreza Campos ^a   Perdigão, Paolla Freitas ^a   Castro, Wagner Henriques ^a   Gomez, Marcus Vinícius ^a   Teh, Bin Tean ^b   Marco, Luiz De ^a   Gomez, Ricardo Santiago ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

HRPT2 gene; Hyperparathyroidism jaw tumour syndrome; Juvenile ossifying fibroma; Ossifying fibroma; Tumour suppressor gene

Indexed keywords

MESSENGER RNA; PARAFIBROMIN; PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CASE REPORT; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENOTYPE; HRPT2 GENE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOLOCALIZATION; JAW TUMOR; MALE; OSSIFYING FIBROMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; TUMOR SUPPRESSOR GENE; WILD TYPE;

ADOLESCENT; ADULT; FEMALE; FIBROMA, OSSIFYING; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MANDIBULAR NEOPLASMS; MIDDLE AGED; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR SUPPRESSOR PROTEINS;

EID: 33746263958     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2005.11.019     Document Type: Article

References (22)

1. Waldron C.A. Fibro-osseous lesions of the jaws. J Oral Maxillofac Surg 51 8 (1993) 828-835
2. Slootweg P.J. Maxillofacial fibro-osseous lesions: classification and differential diagnosis. Semin Diagn Pathol 13 2 (1996) 104-112
3. Barnes L., Eveson J.W., Reichart P., and Sidransky D. World Health Organization classification of tumours. Pathology & genetics head and neck tumours (2005), IARC Press, Lyon
4. Brannon R.B., and Fowler C.B. Benign fibro-osseous lesions: a review of current concepts. Adv Anat Pathol 8 3 (2001) 126-143
5. Sciubba J.J., and Younai F. Ossifying fibroma of the mandible and maxilla: review of 18 cases. J Oral Pathol Med 18 6 (1989) 315-321
6. MacDonald-Jankowski D.S. Fibro-osseous lesions of the face and jaws. Clin Radiol 59 1 (2004) 11-25
7. El-Mofty S. Psammomatoid and trabecular juvenile ossifying fibroma of the craniofacial skeleton: two distinct clinicopathologic entities. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93 3 (2002) 296-304
8. Carpten J.D., Robbins C.M., Villablanca A., et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32 4 (2002) 676-680
9. Teh B.T., Farnebo F., Kristoffersson U., et al. Autosomal dominant primary hyperparathyroidism-jaw tumour syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild-type allele in renal hamartomas. J Clin Endocrinol Metab 81 12 (1996) 4204-4211
10. Szabo J., Heath B., Hill V.M., et al. Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene maps to chromosome. Am J Hum Gent 56 4 (1995) 944-950
11. Chen J.D., Morrison C., Zhang C., Kahnoski K., Carpten J.D., and The B.T. Hyperparathyroidism-jaw tumour syndrome. J Int Med 253 6 (2003) 634-642
12. Howell V.M., Haven C.J., Kahnoski K., et al. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet 40 9 (2003) 657-663
13. Shattuck T.M., Valimaki S., Takao O., et al. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349 18 (2003) 1722-1729
14. Boom R., Sol C.J., Salimans M.M., et al. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28 3 (1990) 495-503
15. Maier J.A., Voulalas P., Roeder D., and Maciag T. Extension of the life-span of human endothelial cells by an interleukin-1 α antisense oligomer. Science 249 4976 (1990) 1570-1574
16. Tan M., Morrison C., Wang P., et al. Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin Cancer Res 10 19 (2004) 6629-6637
17. Jackson C.E., Norum R.A., Boyd S.B., et al. Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome. Surgery 108 6 (1990) 1006-1013
18. Moon S., Park J., Kim E., et al. A novel IVS2-G>A mutation causes aberrant splicing of the HRPT2 gene in a family with hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 90 2 (2005) 878-883
19. Rozenblatt-Rosen O., Hughes C.M., Nannepaga S.J., et al. The parafibromin tumor suppressor protein is part of a human Paf1 complex. Mol Cell Biol 25 2 (2005) 612-620
20. Woodard G.E., Lin L., Zhang J., Agarwal S.K., Marx S.J., and Simonds W.F. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/Prad1 expression. Oncogene 24 7 (2005) 1272-1276
21. Yih W., Pederson G.T., and Bartley M.H. Multiple familial ossifying fibromas: relationship to other osseous lesions of the jaws. Oral Surg Oral Med Oral Pathol 68 6 (1989) 754-758
22. Hauser M.S., Freije S., Payne R.W., and Timen S. Bilateral ossifying fibroma of the maxillary sinus. Oral Surg Oral Med Oral Pathol 68 6 (1989) 759-763